Can You Advertise GLP-1 on Microsoft Ads (Bing)?

What this means for you

• A GLP-1 telemedicine program needs preapproval through Microsoft's Pharmacy and Telemedicine advertiser program form before its ads serve.
• Microsoft's weight loss policy names prescription medications among the things it covers, so GLP-1 ads follow the weight loss rules as well as the prescription rules.
• In the US, compounded weight loss drugs must be labelled "This is a compounded drug" or an equivalent, and nothing may suggest FDA review or approval.
• Weight loss ads must target 18+, encourage a consult with a healthcare professional, and never state an amount or rate of loss.
• Xbox Dash and SwiftKey decline weight loss ads under Microsoft's publisher preferences, so those placements are out of reach.

MedScale Health, a paid acquisition agency for telehealth brands and clinics, gets GLP-1 telehealth brands certified for paid search and builds the ads and landing pages they run. Our answer on Microsoft Ads for telehealth covers the preapproval form and the rules for every health ad. This page covers weight care only: what a GLP-1 or compounded GLP-1 program can run on Microsoft as of October 8, 2026, and what has to change before a Google campaign is imported. This page is marketing guidance, not medical or legal advice. Platform policies change, so check the sources listed at the end before acting on a specific rule.

Two sets of rules apply at once

Microsoft's Healthcare and Pharmaceutical policy, last updated October 5, 2026, says online pharmacies, telemedicine providers that sell prescription drugs and prescription drug manufacturers must be preapproved to serve ads on the Microsoft Advertising network. Its weight loss section covers products, services and programs intended to support weight reduction, and lists medical interventions such as prescription medications and bariatric surgery among them. A GLP-1 telehealth program sits under both: the preapproval rule because it prescribes, and the weight loss rule because of what it treats.

In the United States, online pharmacies that advertise prescription drugs must be accredited by the National Association of Boards of Pharmacy (NABP) or LegitScript. Microsoft's US section adds that prescription drug ads that make a product claim must disclose the risks per FDA guidelines, and that ads marketing to customers outside the US and its territories are not allowed.

The compounded drug label

Microsoft's US weight loss rule reads: "All compounded weight loss drugs must be labeled in accordance with the U.S. Food and Drug Administration (FDA) requirement, including 'This is a compounded drug' or equivalent disclaimer. Labels must not suggest or imply that the drug has been reviewed, approved, or endorsed by the FDA." Neither Meta's Drugs and Pharmaceuticals policy nor Google's Healthcare and medicines policy mentioned compounded drugs when we read them on October 8, 2026, so of the three, Microsoft is the one with the rule in writing.

The FDA sets the same line from its side. Its page for telehealth companies promoting compounded drugs warns against branding that implies the telehealth company is the compounder, calling a compounded drug a generic or the same as an FDA-approved drug, claiming FDA approval, calling it clinically proven to match the approved drug, and claiming it comes from an FDA-approved or FDA-licensed pharmacy, since FDA does not approve or license any facility. On March 3, 2026 the FDA announced 30 warning letters to telehealth companies over compounded GLP-1 claims, citing claims of sameness with approved products and drugs branded with the telehealth firm's name.

Microsoft's wording is about how the drug is labelled. Our practice goes further: wherever a compounded drug is named, in the ad or on the landing page, the compounded line sits next to it, and nothing on either says or implies FDA approval.

Weight loss copy Microsoft won't accept

Microsoft lists content prohibited across all weight loss ads, in a non-exhaustive list:

• Claims that people can lose weight without adopting a healthy lifestyle, or that success needs no lifestyle change.
• Suggestions that results are guaranteed, universal or permanent.
• Any specific amount or rate of weight loss within a defined timeframe.
• Claims of substantial loss regardless of diet or behaviour.
• Content that promotes unhealthy eating habits or negative body image.
• Misleading or manipulated before-and-after imagery that projects unrealistic outcomes.

Weight loss ads must also target 18+ and encourage people to consult a healthcare professional before beginning any intensive program. Microsoft's prescription medicine section adds that ads promoting prescription drugs must not target people based on sensitive health information, must advise following label directions, must warn against exceeding the recommended dose, and must keep claims consistent with the product's indications and warnings.

Where GLP-1 ads won't appear

Microsoft's publisher preferences sit on top of its policies. As of the page's August 24, 2026 update, Xbox Dash ads exclude prescription pharmaceuticals and weight loss, and SwiftKey excludes healthcare ads related to conditions, medication, online pharmacies and weight loss. A compliant GLP-1 ad can still miss those placements, which is a publisher choice, not a disapproval.

Importing a Google GLP-1 campaign

Microsoft's Google Import brings across campaign structure, keywords, ads, creative assets, targeting, bids and budgets, and can run on a daily, weekly or monthly schedule. Microsoft advises reviewing budgets, bids, targeting, ad copy, URLs, conversion goals, tracking and audience settings after any import, because not every setting imports the same way. For a GLP-1 account, we change these before the first import, not after:

• Age targeting set to 18+ on every campaign.
• Every headline and description checked for an amount or rate of loss, which Microsoft does not accept.
• The compounded line added wherever a compounded drug is named.
• Remarketing and audience lists removed, because Microsoft bars targeting based on sensitive health information.
• Scheduled imports paused until Microsoft has preapproved the account, so a Google edit can't push unreviewed drug copy across.

What MedScale does

MedScale Health runs GLP-1 search campaigns on Google for certified brands and pre-checks every ad and landing page against the platform's weight loss and prescription rules before submission. When a brand wants Microsoft as well, MedScale's LegitScript certification help covers the Microsoft preapproval form on the same certified domain, and the landing pages we build already carry the compounded line and the consult-a-professional line Microsoft asks for. MedScale tracks server-side under a BAA with neutral event names, and no names, emails, phone numbers, IP addresses or browser IDs go to any ad platform. Preapproval and results are never guaranteed. Book the free growth audit at medscale.health/audit for a written view on whether Microsoft is worth adding for your program.